Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China
· Delayed Price · Currency is CNY 26.20
+0.01 (0.04%)
At close: Apr 18, 2025, 2:57 PM CST
Tuoxin Pharmaceutical Group Company Description
Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research, development, production, and sale of chemical synthesis, biological fermentation nucleoside (acid) APIs, and pharmaceutical intermediates in China and internationally.
It offers purine base, pyrimidine base, nucleosides, nucleotide, deoxynucleosides, dehyfrated nucleoside, 2'-modified, Cybinucleoside, and sugar series, and Azvudine intermediate.
The company also provides Disodium 5'-cytidylate, Disodium 5'-uridylate, 5'-Adenosine monophosphate, and D-ribose, as well as citicoline sodium, ribavir Lin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, and other APIs and pharmaceutical intermediates.
The company was founded in 2001 and is based in Xinxiang, China.
Tuoxin Pharmaceutical Group Co.,Ltd.
| Country | China |
| Founded | 2001 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,550 |
| CEO | Shaohua Yang |
Contact Details
Address: No. 515, Kelong Avenue Xinxiang, 453000 China | |
| Phone | 86 37 3635 1918 |
| Website | tuoxinpharm.com |
Stock Details
| Ticker Symbol | 301089 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004YC3 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Shaohua Yang | GM and Non-Independent Director |
| Huijuan Jiao | Chief Financial Officer |
| Xiuqiang Wang | Deputy GM and Director |
| Yuhua Yang | Board Secretary |
| Tao Li | Deputy General Manager |